Troutfish,Spot on , and not an incling of ramping, just well researched, and common sense.Well PlayedRevenues will grow on this stock way before US FDA, just watch.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
